3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
10
Neoplasm Metastasis
9
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Prostatic Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Ovarian Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioblastoma
2
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymoma
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Non Castrate Metastatic Prostate Cancer
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
5
pimonidazole
4
fluoroazomycin arabinoside
4
Radiotherapy
4
Injections
3
Propofol
2
Positron Emission Tomography Computed Tomography
2
Drug Therapy
2
Blood Specimen Collection
2
pembrolizumab
1
inositol trispyrophosphate
1
gadobutrol
1
fludarabine
1
alovudine
1
Thoracotomy
1
Thoracic Surgery, Video-Assisted
1
Temozolomide
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Saline Solution
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxygen
1
Nitroglycerin
1
NVP-BKM120
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Letrozole
1
Hydroxychloroquine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hypoxia
×
NVP-BKM120
×
Clear all
NCT02128724
2019-08-01
BKM120
University of Oxford
Phase 1
Completed
21 enrolled
23 charts